International Journal of Cancer

Cover image for Vol. 139 Issue 11

Editor-in-Chief: Professor Peter Lichter, DKFZ, Germany

Impact Factor: 5.531

ISI Journal Citation Reports © Ranking: 2015: 29/213 (Oncology)

Online ISSN: 1097-0215

Recently Published Issues

See all

Read the Latest from IJC

New Content from IJC

IJC Accepted Articles(accepted manuscripts)
Accepted Articles have been accepted for publication in IJC, but have not undergone the editing and proof-correction process. Accepted Articles are citable by DOI.

IJC Early View(e-pub ahead of print)
Early View articles are definitive in format and presented in advance of print publication.

Professor Lichter's Top Picks

Read Now

Editor's Choice from IJC


Access the monthly Editor’s Choice article FREE!

2016 (Volume 139)

December (Issue 11)

Cell autonomous or systemic EGFR blockade alters the immune-environment in squamous cell carcinomas
Francesca Mascia, Derek T. Schloemann, Christophe Cataisson, Katherine M. McKinnon, Ludmila Krymskaya, Karen M. Wolcott and Stuart H. Yuspa

November (Issue 10)

A prospective study of dietary patterns and cancer mortality among Blacks and Whites in the REGARDS cohort
Tomi Akinyemiju, Justin Xavier Moore, Maria Pisu, Susan G. Lakoski, James Shikany, Michael Goodman and Suzanne E. Judd

November (Issue 9)

OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models
Caroline Berenguer-Daiz, Lucile Astorgues-Xerri, Elodie Odore, Mylène Cayol, Esteban Cvitkovic, Kay Noel, Mohamed Bekradda, Sarah MacKenzie, Keyvan Rezai, François Lokiec, Maria E. Riveiro and L’Houcine Ouafik

October (Issue 8)

Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy
Roni Oren, Yoseph Addadi, Lian Narunsky Haziza, Hagit Dafni, Ron Rotkopf, Gila Meir, Ami Fishman and Michal Neeman

October (Issue 7)

Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer
Vijayalakshmi Thamilselvan, Mani Menon and Sivagnanam Thamilselvan

September (Issue 6)

Tyrosine kinase inhibitor sunitinib therapy is effective in the treatment of bone metastasis from cancer of unknown primary: Identification of clinical and immunohistochemical biomarkers predicting survival
Yifei Ma, Wang Zhou, Shaohui He, Wei Xu and Jianru Xiao

Click the button for

Editors' Choice

Joint IJC & Klaus Tschira Stiftung Lectureships

IJC Lectureships

The Joint IJC and Klaus Tschira Stiftung Lectureship at the German Cancer Research Center (DKFZ) in Heidelberg honors three to four leading scientists in the field of cancer research each year. The videos from the lectures in 2012, 2013 and 2014 can be found under “Special Features”.

COPE

IJC COPE JPG

The International Journal of Cancer has been a member of COPE since 2008.

SEARCH

SEARCH BY CITATION